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P urpose. A substantial proportion o f  the population at risk for 
visual loss from age-related macular degeneration consumes 
supplements containing high doses o f  lutein, but clinical stud­
ies to date have shown only modest and variable increases in 
macular carotenoid pigments in response to supplementation. 
To determine whether lutein supplementation can indeed alter 
ocular carotenoid levels, the authors chemically measured lev­
els o f  lutein, zeaxanthin, and their metabolites in the macula, 
peripheral retina, and lens o f  228 eyes from 147 human donors 
and correlated these results with retrospective supplement 
histories from families o f  selected members o f  the study pop­
ulation.
M eth o d s . Lenses and circular punches o f  macula (4 -m m  diam­
eter) and equatorial peripheral retina (B-mm diameter) were 
dissected from donor eyes free o f  ocular disease procured from 
the local eye bank. The amounts o f  lutein, zeaxanthin, meso- 
zcaxanthin. and 3'-oxolutein were determined by HPLC with 
photodiode array and mass spectral detection.
R esults. Eighteen percent o f  eyes from donors age 48 and older 
had unusually high levels (66.3 ± 1 5 .1  ng) o f  macular carote- 
noids that were three times the rest o f  the older population’s 
mean level (23.0 + 1 2 .1  ng; P <  0.001). Carotenoid levels in 
these outliers were also unusually high in the lens and in the 
peripheral retina. Similar outliers were not present in donors 
younger than 48. Most o f  these outliers regularly consumed 
high-dose lutein supplements before death. Lutein supplemen­
tation was uncommon in older donors w hose macular carote- 
noids were in the normal range.
C onclusions. The presence o f  unusually high levels o f  macular 
carotenoids in older donors w ho were regularly consuming 
high-dose lutein supplements supports the hypothesis that 
long-term lutein supplementation can raise levels o f  macular 
pigment. Klevated carotenoid levels in the peripheral retina 
and lens in these same donors could have important implica­
tions for understanding w hy some clinical methods o f  macular 
pigment measurement have had difficulty detecting robust and 
consistent responses in carotenoid supplementation trials. (In­
vest Ophthalmol Vis Sci. 2007;48:543-549) 1)01:10.1167/ 
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T n the past decade, a profound shift has occurred in the 
X  clinical management o f  patients at risk for visual loss from 
age-related macular degeneration (AMD).1""1 AMD had long 
been considered to be in part a disorder related to chronic 
oxidative stress, but it was not until release o f  the results o f  the 
Age-Related Kye Disease Study (ARKDS) in 2001 that definitive 
clinical recommendations could be made o f  the value o f  anti­
oxidant supplementation in patients at high risk.5 The ARKDS 
formulation o f  high-dose zinc, vitamin C, vitamin K, and /3-car­
otene was based on the best nutritional recommendations at 
the inception o f  the study in the 1980s, but subsequent studies 
indicated that other nutrients may be even more valuable in the 
prevention o f severe visual loss from AMD.C’ " S The macular 
xanthophyll carotenoids, lutein and zeaxanthin, are o f  partic­
ular interest because, unlike 0-carotene, they are specifically 
concentrated in the foveal region o f  the primate macula, where 
they can act as antioxidants and as optical filters for blue light, 
the most phototoxic region o f  the visible spectrum.9-11 In the 
mid-1990s, publication o f a series o f  studies from the Kye 
Disease Case-Control (KDCC) Study Group demonstrated that 
persons with high b lood  levels o f  lutein and zeaxanthin and 
high consumption o f  foods rich in these same carotenoids had 
significantly lower risk o f  exudative AMD,12-13 and a number o f  
subsequent independent epidemiologic studies and the ARKDS 
study group have confirmed these findings.13-1J Based on these 
results, it has becom e commonplace to add high doses o f  lutein 
(typically 6 -2 0  mg/day as opposed to average dietary con­
sumption o f 1-2 mg/day) to supplements marketed to the 
elderly at risk for visual loss from AMD. Supplements contain­
ing high levels o f  zeaxanthin are also available, but their use is 
still uncommon. A follow-up study to ARKDS (ARKDS II), which 
will incorporate lutein and zeaxanthin supplementation, has 
been initiated to provide definitive prospective recommenda­
tions on the value o f  these supplements for AMD.
Carotenoid supplementation strategies for AMD rely on the 
assumption that consumption o f  these supplements will lead 
to clinically significant increases in the macular carotenoid 
pigment, but published and unpublished studies have reported 
unexpectedly modest and variable responses despite consis­
tent increases in serum levels.15-23 Possible explanations o f 
these results include inadequate study length, saturation o f 
ocular xanthophyll-binding proteins, and inherent limitations 
o f  the noninvasive measurement methods. The most com ­
monly used noninvasive measurement methods, heterochro- 
matic flicker photometry and autofluorescence imaging, oper­
ate under the premise that carotenoid levels at a peripheral 
retinal reference point are so low  that they are optically unde­
tectable.2' ~29 This assumption has been well validated by studies 
on primate cadaver eyes that demonstrated the concentration 
o f  macular carotenoids per unit area measured by absorption 
spectroscopy, resonance Raman spectroscopy, and high-pres­
sure liquid chromatography (HPLC) is 10 to 100 times higher in 
the macula than it is in the peripheral retina.9" 11-30_3‘1 It should 
be noted, however, that this assumption cannot be simply 
extrapolated to the supplemented situation because these au­
topsy studies were conducted before the lutein supplementa­
tion era. It is possible that the pharmacologic doses o f  lutein 
currently consumed by many elderly persons could lead to
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substantial increases in peripheral lutein levels that would 
artifactually alter noninvasively measured macular responses. 
To assess this possibility, w e measured ocular carotenoid levels 
by HPLC in a large number o f human donor eyes now  that 
high-dose lutein supplementation has becom e a com m on prac­
tice among older adults in Utah.
M et h o d s
Chemicals
Standards of (3i?.3'i?.6'i?>lut.ein. zeaxanthins [(3i?.3'A'-»»fso>zeaxan- 
thin and dietary (3i?.3 'i?>zeaxant.hin]. and 3 '-oxolut.ein w ere generous 
gifts from Kemin Health (Des Moines. IA). DSM (Schaffhausen. SH. 
Switzerland), and BASF (I.udwigshafen. Germany), respectively. They 
w ere individually dissolved in hexane containing 0 .1 % but.ylat.ed hy- 
droxytoluene (BHT) at concentrations o f 1 fxg/ml„ stored at -70°C. and 
brought to room tem perature before use. Composite working standard 
solutions were prepared by combining suitable aliquots o f each indi­
vidual standard stock solution and diluting them with HPI.C mobile 
phase. Organic solvents were HPI.C grade from Fisher Scientific 
(Hampton. NH).
Preparation of Macular, Retinal, and Lens 
Tissue Samples
Human donor eyes w ere obtained betw een January 2004 and April 
2005 from the Utah Lions Bye Bank w ithin 24 hours o f death after 
corneas had been harvested for transplantation. Tissue p rocurem ent 
and distribution com plied w ith the tenets o f the  Declaration of 
Helsinki. All eyecups w ere visually inspected  to  exclude the  pres­
ence of obvious ocular disease. After carefully removing overlying 
vitreous, m acular tissue was excised w ith a j-m m -d iam ete r circular 
treph ine cen tered  on the  fovea, and peripheral equatorial retinal 
tissue was excised w ith an 8-m m-diamet.er circular treph ine, mak­
ing certain th a t the  nearest edge of the  punch was at least 10  mm 
from the  fovea. Tissue samples w ere ex tracted  th ree  times with 
tetrahydrofuran (THF) containing 0.1% BHT by sonication at 5°C to 
10°C for 30 m inutes each tim e. W hole lenses w ere hom ogenized 
and then  ex tracted  in the  same m anner. Com bined extracts w ere 
evaporated to  dryness under vacuum at room tem perature. The 
dried residue was re-dissolved in 1 ml, HPI.C m obile phase and 
centrifuged at approxim ately 2000g  for 10  m inutes to  remove the 
m inor am ounts o f insoluble solid particles.
HPLC Conditions
The extracts were analyzed on tw o HPI.C systems on a gradient HPI.C 
(Thermo Separations. San Jose. CA) equipped with a high-sensitivity 
L V6000 photodiode array detector.
System 1: Routine Carotenoid Separation. The mobile 
phase contained hexane/dichloromethane/methanol/iV.A7'-di-isopropyl- 
ethylamine (80:19.2:0.7:0.1 vol/vol). HPI.C separation was carried out 
at a flow rate o f 1.0 m l/m in on a cyano column (Microsorb. 25-cm 
length X 4.6-mm inner diameter [ID]: Rainin Instrument. Co.. Woburn. 
MA). The column was maintained at room tem perature, and the HPI.C 
detector was operated at 450 nm. Peak identities were confirmed by 
photodiode-array (PDA) spectra, by coelution with authentic stan­
dards. and by mass spectrometry. Calibration curves for peak quanti­
tation were performed by injection o f known amounts o f carotenoid 
standards. We do not routinely include an internal standard because it 
can mask the presence of low abundance carotenoid metabolites, 
especially when samples are split and run on multiple HPI.C col­
umns.3’ We periodically perform quality control runs to confirm that 
our extraction and injection efficiencies exceed 95%.
System 2: Chlral Carotenoid Separation. The mobile 
phase contained hexane/isopropanol (95:5 vol/vol). HPI.C separation 
was carried out at a flow rate o f 0.7 m l/m in on a chiral column 
(ChiralPak AD. 25-cm length X 4.6-mm TD: Chiral Technologies. Exton. 
PA) using the detection methods described.
Mass Spectrometry Equipment and Conditions
levels o f ocular carotenoids and their metabolites were sometimes so 
low that, reliable quantitation by absorbance at 450 nm was not possi­
ble. Tn these situations, we used in-line mass spectrom etry analysis 
because it is approximately 100 times more sensitive.36 HPI.C-MS was 
performed (Thermo Electron MSQ. San Jose. CA) with a single quad- 
rupole mass spectrom eter equipped with an atmospheric pressure 
chemical ionization (APCT) source after a 50% split o f the column 
eluant. The molecular ions w ere initially acquired in full scan mode 
from 200 to 1000 Da with 0.2-st.ep size and 2-ms dwell time. Selected 
ion monitoring (STM) was performed using a dwell time of 200 ms for 
each channel. Tn STM mode, the m /z  channels 551 ±  1 (M-H_,0 ’) and 
569 ±1 (M ’) were used for lutein. 569 ±  1 for zeaxanthin (M ’). and 
567 ±  1 for 3'-oxolut.ein (M ’). Typical conditions w ere corona dis­
charge current.. 5 ft A: RF lens bias voltage 0.1 V: cone voltage. 80 V: 
and heater temperature. 550°C. The ion source and tuning lens param­
eters were optimized by infusing standards through the built-in injec­
tor. For routine quantitative analysis, we used software (ThemoElec- 
tron MSQ Quan Browser: XCaliber Systems. Brazil. TN) that, provided a 
peak integration of the ion intensity for each of the programmed mass 
ranges against standard curves generated from injection of authentic 
carotenoid standards. Automated analysis was followed by manual 
confirmation of in-source fragmentation patterns.
Statistical Analysis
Statistical analysis was performed (Origin version 6.0: Microcal. 
Northampton. MA). Tn most cases a two-population (independent) t 
test was perform ed with a significance level set at 0.05. All reported 
values are mean ±  SD.
R esults
Total carotenoid levels were determined in 4-mm-diameter 
macular punches from 228 eyes from 147 donors ranging in 
age from 5 to 86 (Fig. 1A). Visual inspection o f the data 
revealed that a cohort o f  donors 48 and older had unusually 
high levels (> 5 0  ng) o f  total carotenoids. We designated this 
population as outliers for further analyses. These outliers com ­
prised 13% o f total eyes (29 /228) and 18% o f older eyes (29 / 
160) and 14% o f  total donors (21/147) and 21 % o f older donors 
(21/99).
The average age for outlying donors was 65 ±  10 (range, 48 
to 84; ii = 21) years, and the “normal'’ older donor age was 
64 ±  9 (range, 48 to 86; n = 78) years. The mean total macular 
carotenoid level o f older outlier eyes was 66.3 ±  15.1 ng (11 = 
29), and the mean for the rest o f the older donor eyes was 
23.0 ±  12.1 ng (n  = 131). These means were significantly 
different from each other (P <  0.001). A similar analysis in 
which all pairs o f older donor eyes (n  = 45 pairs) were 
averaged before statistical testing yielded a comparable statis­
tically significant result (P  <  0.001). Our nonoutlier macular 
carotenoid density o f  1.79 n g /m n r for a 4-mm punch com ­
pares favorably with previously published values o f  1.69 
n g /m n r for 4.6-mm pu nch es11 and 1.39 n g /m n r for 8-mm 
punches . 10
Both eyes were available for analysis in 15 o f the 21 outlying 
donors. The concordance rate ( > 5 0  ng in both eyes) o f these 
outliers was 5 3 %  (8  / 1 5 pairs). The average level o f  carotenoids 
in the fellow eyes o f discordant outliers ( 3 9 .8  ±  4 .4  ng; 11 = 7 )  
was 4 5 %  less than that o f the outlier eyes themselves (7 2 .1  ±  
2 5 .2 ; n = 7\ P  <  0 .0 0 1 )  but was significantly higher than the 
mean value o f the rest o f  the “normal" older eyes (21.3 ±  11.3 
ng; 11 = 12 4 ; P  <  0 .0 0 1 ) .
Retrospective nutritional supplement and dietary histories 
were obtained from the families o f  17 o f the 21 outliers and
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F ig u r e  1 . Age distribution of total 
carotenoids (A), dietary (Jif, 
3 'if,6 'i?>lutein (B), total zeaxanthin 
(C), dietary (3if, 3'i?>zeaxant.hin (D), 
(3if,3 'A-»*fso>zeaxanthin (E), and 3 '- 
oxolutein (F) in normal (open cir­
cles) and outlier (filled circles) eyes. 
Discordant fellow eyes of outliers are 
shown as open squares. Carotenoids 
w ere extracted from 4-m m-diameter 
macular punches (n -  228) and an­
alyzed by HPLC-APCT/MS. All figures 
w ere partitioned to highlight the fact, 
that outliers were 48 years of age or 
older and had unusually high levels 
(> 50  ng) o f total carotenoids.
from a random sample o f  20 o f the rest o f  the older donors. 
Bighty-two percent (14/17) o f  the outliers’ families reported 
that the donor regularly consumed a high-dose (2 .5 -10  mg) 
lutein supplement daily, and the rest o f  the outliers’ families 
reported that before death, the donor routinely consumed an 
unusually carotenoid-rich diet daily including spinach, corn, 
broccoli, and orange juice. None o f  the 20 nonoutliers’ families 
surveyed reported regular lutein supplementation or consump­
tion o f a carotenoid-rich diet (P  <  0.001).
None consumed supplements that contained high percent­
ages o f  zeaxanthin, though it should be noted that commercial 
lutein supplements typically contain 6% zeaxanthin, which 
w ould supply 0.36 to 1.2 mg o f zeaxanthin from a 6- to 20-mg 
lutein supplement. The family o f  a 52-year-old outlier reported 
a diet unusually rich in zeaxanthin (daily servings o f  corn), and 
this donor had the highest dietary zeaxanthin level in the 
macula o f  any eye analyzed (Fig. ID).
We determined which carotenoids were responsible for the 
extraordinarily high levels in the outliers’ maculae. The high 
levels o f  total macular carotenoids were driven primarily by 
lutein and, to a lesser extent, by its probable metabolite meso- 
zeaxanthin (Figures 1B-1B). The average lutein levels were 
2 7 .7  ±  8 .9  ng in outlier eyes ( «  =  2 9 )  and 9 .3  ±  5 .8  ( «  =  1 3 1 )  
in the rest o f  the older eyes (P <  0.001), and the average total 
zeaxanthin in outliers was 2 4 .0  ±  1 0 .9  ( «  =  2 9 )  compared
with 10.1 ±  6.8 ( «  =  131) in the rest o f  the older eyes (P <  
0.001). We observed that the mean values for dietary (3A’ . 
3'^>zeaxanthin were not statistically significant (P  =  0.38) for 
outlier eyes (13.3 ±  6.9 ng; n =  16) than they were for older 
normal eyes (10.1 ±  7.1 ng; n =  94). However, significantly 
higher levels o f  nondietary (3/f, 3'5-?we«0-zeaxanthin were 
observed in the outlier eyes (19.4 ± 1 4 .1  ng; n =  16) than in 
older normal eyes (7.4 ±  9.6 ng; n =  107; P  <  0.001). 
Similarly, the ratio o f  (3/f,3'/f>zeaxanthin to 0P 3 'S -m esoy  
zeaxanthin ( / . /M ratio) was significantly lower in outlier eyes 
than in control eyes (Table 1). 3 '-O xolutein was not signif­
icantly higher in outlier eyes than in age-matched normal 
eyes (1.9 ±  1.3 ng [n =  16J vs. 1.2 ±  1.8 ng [n =  60J; P  >  
0.05; Fig. IF).
We next examined whether carotenoid levels were elevated 
in nonmacular tissues o f  the outliers’ eyes (Fig. 2). Although 
data on extramacular tissue were available for only a limited 
number o f the donor eyes, lutein levels were significantly 
elevated in the outliers in the peripheral retina (P <  0.001), but 
total zeaxanthin levels were not elevated (P =  0.12). Lutein 
levels in 8-ram punches o f  the peripheral retina were 8.4 ±  6.6 
ng ( «  =  9) compared with 2.2 ±  1.4 ng in older normal retinas 
( «  =  32; Table 1). Our nonoutlier peripheral carotenoid 
density o f  0.070 ng/m m 2 for an 8-ram equatorial punch 
com pares favorably with previously published values o f
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Young 9.4 ±  4.5 10.8 ±  7.0 1.70 ±  0.23 0.6 ±  0.5 21.4 ± 1 1 .0
(n -  68) (n -  68) (n -  68) (n -  68) (n -  68)
Old 9.3 ±  5.8 10 .1 ±  6.8 1.36 ±  0.31 1.2  ±  1 .8t 23.0 ± 12 .1
in = 131) (n = 131) in -  94) (n -  60 i (n = 131)
Outliers 27.7 ±  8.9* 24.0 ±  10.9* 0.68 ±  0 .30* 1.9 ±  1.3 66.3 ±  15.1*
(n = 29) (n = 29) (n -  16 ) (n -  16 ) (n = 29)
Peripheral retina (8-nim-diamet.er punch)
Young (n — 32) 2.5 ±  1.2 1.1 ±  0.7 ND ND 3.6 ±  0.7
Old (n =  32) 2.2 ±  1.4 1.0  ±  1 .1 ND ND 3.4 ±  1.8
Outliers (n -  9) 8.4 ±  6.6* 0.7 ±  0.4 ND ND 9.0 ±  5.6*
Lens (whole tissue)
Young (n -  30) 0.5 ±  0.3 0.4 ±  0.2 ND ND 0.9 ±  0.2
Old {n - 5 1 ) 0.7 ±  1.7 0.4 ±  0.2 ND ND 1.5 ±  1.6
Outliers (n -  8) 4.9 ±  2.9* 0.9 ±  0.4* ND ND 5.8 ±  2.4*
AH values are mean ±  SD. Young donors w ere less than 48 years old. Old donors and all outliers w ere at least 48 years old. Zeaxanthin, 
combined dietary (3i?,3'i?)-zeaxanthin and non-dietary (3i?,3'S-»»fso>zeaxanthin: Z/M Ratio, the ratio of (3i?,3'i?)-zeaxanthin to (3i?,3'S-meso)- 
zeaxanthin in macular tissues: ND, not determined.
* Statistically significant differences betw een the outliers and the age-matched normals a  48 years old (all P < 0.001). 
t  There w ere no significant differences betw een young and old normals (all P > 0.05) except in the case of 3'-oxolut.ein (P < 0.001).
0.067 to 0.047 n g /m m ' at 5.8 to 12.2 mm eccentricity .11 On 
average, the peripheral lutein/zeaxanthin ratio in outlier 
eyes was highly unusual: 12.0:1 com pared with that o f  older 
normal eyes, 2.2:1.
In the lens, outliers had significantly higher levels o f  lutein 
and total zeaxanthin (P <  0 .0 0 1 ; Fig. 2 ). Lutein and zeaxanthin 
levels were 4 .9  ±  2 .9  ng/lens (n  = 8 )  and 0 .9  ±  0 .4  ng/lens 
Ol =  8 ) , respectively, compared with a lutein level o f  0 .7  ±  1.7  
ng/lens and a zeaxanthin level o f  0 .4  ±  0 .2  ng/lens in older 
normal eyes (n  = 5 1 ; Table 1). In addition, the ratio o f  lutein 
to total zeaxanthin in the outlier eyes was observed to be 
higher ( 5 .4 :1 )  than in older normal eyes ( 1 .8 :1 ) .
D isc u ssio n
Our finding that approximately 20% o f older donors in Utah 
have extraordinarily high levels o f  macular carotenoids, three 
times the general population’s average, is striking evidence of 
the impact o f recent public health recommendations for any­
one at risk for visual loss from AMD to increase antioxidant 
consumption. The outliers were always in the upper age range, 
consistent with product marketing campaigns for high-dose 
lutein supplements that primarily target the elderly, and we 
were able to confirm retrospectively that most o f these outly­
ing donors did indeed consume high-dose lutein supplements
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F ig u r e  2 .  Age distribution of di­
etary lutein and total zeaxanthin 
from peripheral retina (8-mm- diam­
eter punches) and whole lens in nor­
mal (open circles) and outlier (flUed 
circles) eyes. Discordant fellow eyes 
of outliers are shown as open 
squares.
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regularly before death. Increases in macular carotenoid levels 
were driven primarily by lutein and its probable metabolite 
wesozeaxanthin. On the other hand, levels o f dietary zeaxan­
thin and its possible metabolite 3'-oxolutein were not elevated, 
consistent with the current rarity o f high-dose zeaxanthin sup­
plementation in Utah.
W e also found that, on average, donors with high levels o f 
macular carotenoids had significantly elevated levels o f  carote­
noids in lens and peripheral retina. Elevated lutein levels were 
consistently encountered in the lens (range, 2- to 10-fold above 
average), which may explain w hy some studies have impli­
cated lutein as a protective nutritional factor against cata­
racts.37'38 They w ere more variable, however, in the peripheral 
retina (range, 1- to 10-fold above average). Increased carot­
enoid concentrations in the lens and in the peripheral retina in 
response to supplementation could have profound effects on 
the various methods used to quantity macular pigment in living 
human eyes.
Ueterochromatic flicker photometry (HFP) is the most com ­
monly used method to measure macular pigment in clinical 
research. I7' lf!'2"1'26'27"39'"1" A small spot o f  light projected onto 
the fovea rapidly alternates between blue, which is well ab­
sorbed by the macular carotenoids, and green, which is not. 
The subject varies the relative intensities o f  the tw o lights until 
the perception o f  flicker is minimized or eliminated, and the 
average energy7 o f  the blue light (Elnv) at minimal flicker from 
multiple tests is recorded. Because subjects vary markedly in 
the ratio o f  L and M cones that mediate color perception in 
HFP, the test must be repeated with an eccentric reference 
fixation point. To determine Hn,t, macular pigment optical 
density (MPOD) is assumed to be zero. Typical reference 
points are at 4° to 9° eccentricity (1 .2-2 .6  mm at the retinal 
surface). The MPOD is then calculated with the equation 
MPOD =  log The zero MPOD assumption at ap­
proximately 7° is likely to be reasonable in an unsupplemented 
primate eye based on microspectrophotometry using absor­
bance and resonance Raman techniques in cadaver eyes,32-3-1 
but our data in this study raised questions as to whether this 
assumption remains valid in the supplemented state. In some 
subjects, substantial increases in carotenoid content (up to 
10-fold) are exhibited in the equatorial region, very far beyond 
the traditional reference point o f  approximately 7°. W e calcu­
lated that the average optical density attributable to xantho- 
phyll carotenoids in the equatorial retina in one o f  these do­
nors would be up to 0.01 at 460 nm. This w ould introduce a 3% 
underestimate o f foveal MPOD for a subject with a typical 
foveal MPOD o f 0.3, which is not particularly problematic if 
the equatorial periphery w ere used for Hn,t. In HFP, however, 
Bref is less than 2.6 mm from the center o f  the fovea. It is not 
unreasonable to predict that MPOD at approximately 7° might 
be in the 0.1 range or even higher in a supplemented subject 
because o f a steep gradient o f  xanthophyll concentration from 
the periphery to the fovea, as evidenced in a previous human 
retinal HPLC microdissection study demonstrating that macular 
carotenoid levels at this eccentricity are typically more than 10 
times higher than at the equatorial periphery.' '  This level o f 
MPOD at ISrri w ould introduce a very large and potentially 
variable error in the foveal MPOD calculation (up to a 30% 
underestimate for a typical foveal MPOD o f 0.3 or a 10% 
underestimate for a very high foveal MPOD o f 1.0). The best 
way to avoid this problem w ould be to place Hn,t as far as 
possible in the periphery. Unfortunately, reliable psychophys­
ical performance o f HFP much beyond 7° (i.e., > 14 °) is ex­
traordinarily difficult.
Autofluorescence (AF) measurement o f  macular pigment is 
based on the measurement o f  attenuation o f lipofuscin’s inher­
ent fluorescence by xanthophyll carotenoids.25'28'29"11 In its 
most typical form, blue monochromatic light excites lipofus­
cin’s main A2E fluorophore, which fluoresces at long wave­
lengths. Lutein and zeaxanthin are essentially nonfluorescent 
and absorb incident blue light, thereby attenuating A2E’s fluo­
rescence in the fovea. This method is amenable to high-reso- 
lution imaging with a digital camera or a scanning laser oph­
thalmoscope (SLO). If performed with a single wavelength, 
such as 488 nm, an assumption o f reasonably uniform lipofus­
cin distribution and zero MPOD in the periphery must be 
made. The problems related to carotenoid supplementation 
discussed for HFP w ould therefore apply. Fortunately, a more 
peripheral reference point (i.e., > 1 4 °) could be chosen with 
this optical method. Sometimes the investigators make a sec­
ond AF image with a green wavelength, such as 514 or 532 nm, 
that is not absorbed by carotenoids and that can then be used 
for digital subtraction from the 488-nm image to correct for 
inhomogeneities o f  lipofuscin distribution and various abnor­
malities. Zero MPOD assumption is still generally required.
Dual-wavelength reflectometry has also been performed 
using an SLO platform at 488 and 514 nm and a zero reference 
point o f  14°.22'~*2 This method’s performance in a supplemen­
tation study w ould be expected to be comparable to AF imag­
ing given that the assumptions are similar. Reflectometry can 
also be implemented in a quantitative nonimaging mode in 
w hich the fovea is illuminated with a series o f  narrow-bandpass 
filters, and a sophisticated optical model is used to calculate 
the average spectral contribution o f the absorbance o f  the 
macular carotenoids. This method should be unaffected by 
peripheral changes in carotenoid content. On the other hand, 
changes in optical density o f  the lens in response to carotenoid 
deposition (approximately 0.01 optical density units) should 
be incorporated into the model or an overestimate o f foveal 
MPOD will result.
Resonance Raman spectroscopy (RRS) has been used as a 
specific optical method to measure macular carotenoid pig­
ments in the living human eye.21 •32-'*3 Light (488 nm) is briefly 
illuminated on a 1-mm-diameter region o f  the macula centered 
on the fovea, and wavelength-shifted light is analyzed on a 
Raman spectrometer. The intensity o f  the xanthophyll carote­
noids’ C =  C vibration at 1525 cm "1 is linearly associated with 
macular carotenoid content. In the originally described integral 
mode, no peripheral correction is required; thus, values would 
be unaffected be any changes in the periphery, but substantial 
lens opacities or increases in lens carotenoid content could 
alter the values. Absorbance o f  the incident 488-nm laser light 
by carotenoids in the lens would mildly attenuate the observed 
Raman-shifted signal causing an underestimate o f  the foveal 
carotenoid content, but this w ould be counteracted by an 
opposing increase in the measured Raman signal from the lens 
carotenoids themselves. In the future, carotenoid supplemen­
tation studies using RRS should include a sufficient number of 
pseudophakic subjects to assess the magnitude o f this potential 
problem in phakic subjects.
HPLC is sometimes referred to as the “gold standard" of 
ocular carotenoid measurement, but this technique has its own 
limitations, too. Although it is the most chemically specific, its 
sensitivity and spatial resolution cannot match any o f the op­
tical detection methods. In the past, w e have consistently 
observed an age-related decline o f  macular pigment in our Utah 
clinic population with a variety o f  techniques, including RRS, 
AF imaging, and HFP,21"1""12 but w e did not observe such a 
decline in this HPLC study. Possible explanations include the 
fact that w e used 4-mm tissue punches, which might blunt any 
age-related changes o f  foveal MPOD observed with methods 
with higher spatial resolution and which look at regions with 
diameters measuring 1 mm or less. In addition, all our studies 
in living humans specifically recruited clinic-based subjects 
w ho were not routinely consuming high-dose carotenoid sup­
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plements, whereas the present study accepted all donor eyes 
regardless of supplementation history.
The findings reported here of elevated lenticular and retinal 
levels of ocular carotenoids apply only to  lutein supplements 
because high-dose zeaxanthin supplementation is still too rare 
in our population. Zeaxanthin is more selectively concentrated 
in the fovea, w here its binding protein, GSTP1, is found in very 
high concentrations. 11 Hence, peripheral retinal rises in re­
sponse to supplementation may not be as high as they were 
with lutein. Lutein’s binding protein in the human retina is still 
not identified, but w e have partially purified one from human 
and quail liver (Bhosale P et al. JOVS 2005;46;ARVC) F-Abstract 
1756). This lutein-binding protein induces a large red shift of 
its carotenoid ligand’s absorbance, which may also have im­
portant implications for the various noninvasive methods of 
carotenoid measurement.
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